Magnolia Medical Technologies, Inc. v. Kurin, Inc.

  1. May 14, 2024

    Jury's $2M Medical Device Infringement Verdict Upended

    A Delaware federal judge ruled Tuesday that Kurin Inc. did not infringe claims of a Magnolia Medical Technologies Inc. patent tied to sepsis testing, reversing a 2022 jury verdict that Kurin had infringed the patent and should pay $2 million.

  2. July 29, 2022

    Sepsis Testing Trial Ends In $2.1M Patent Verdict In Del.

    A medical device startup failed to convince jurors in Delaware that a rival's patent covering a new method of testing for sepsis was already covered by decades-old research, leading to an infringement verdict that totals at least $2.1 million in royalties, as well as an ongoing $2.66 royalty on every kit sold.

  3. July 26, 2022

    Del. Jury Finds Kurin Infringed Rival's Blood-Testing Patent

    A Delaware federal jury found Tuesday that Kurin Inc.'s blood-testing products infringe Magnolia Medical Technologies Inc.'s blood-testing patent in the first phase of the two-part jury trial, sending the case to a second trial to determine the amount Kurin owes in damages for the infringement.

  4. July 14, 2022

    IP Forecast: 'Pulp Fiction' NFT Feud To Play In LA Court

    A federal judge in Los Angeles next week will hear lawyers for director Quentin Tarantino argue that a non-fungible token that recently sold for more than $1 million was based on his own handwritten screenplay for "Pulp Fiction" and doesn't belong to the movie studio that owns the copyright on his hit 1994 movie. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.